Home » Affomix to Provide Antibodies for Kalgene Pharmaceutical’s Diagnostics Program
Affomix to Provide Antibodies for Kalgene Pharmaceutical’s Diagnostics Program
Affomix Corporation … announced that Kalgene Pharmaceuticals Inc. has signed a commercial agreement to have Affomix utilize its Y2HExpress technology
to select antibodies with potential diagnostic and therapeutic utility in breast cancer.
Forbes
Forbes
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May